These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25168841)

  • 41. AFSSAPS market survey of total PSA, free PSA and complexed PSA assay kits.
    Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
    Prog Urol; 2007 Apr; 17(2):176-7. PubMed ID: 17489313
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?
    Favaloro EJ; Plebani M; Lippi G
    Clin Chem Lab Med; 2011 Aug; 49(12):1965-73. PubMed ID: 21875399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Are blood glucose analyzers safe? Experiences of the BfArM based on all notifications received until end of 2005].
    Siekmeier R; Lütz J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Dec; 49(12):1212-8. PubMed ID: 17149661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Turf war over diagnostic testing.
    Tempero M
    J Natl Compr Canc Netw; 2015 Apr; 13(4):375. PubMed ID: 25870372
    [No Abstract]   [Full Text] [Related]  

  • 45. [The principle of registration, evaluation and testing of disinfecting preparations].
    Röhm-Rodowald E; Jakimiak B; Podgórska M
    Przegl Epidemiol; 2008; 62(3):661-8. PubMed ID: 19108531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The European experience with third-party certification.
    Dobbs H
    Biomed Instrum Technol; 1996; 30(5):455-7. PubMed ID: 8909707
    [No Abstract]   [Full Text] [Related]  

  • 47. Missing data in the regulation of medical devices.
    Campbell G; Pennello G; Yue L
    J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of novel IVD assays: a manufacturer's perspective.
    Metcalfe TA
    Scand J Clin Lab Invest Suppl; 2010; 242():23-6. PubMed ID: 20515272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experiences and recommendations of the German Federal Institute for Drugs and Medical Devices (BfArM) concerning clinical investigation of medical devices and the evaluation of serious adverse events (SAE)].
    Renisch B; Lauer W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1368-75. PubMed ID: 25376539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CDx, NGS and regulation: five perspectives from the Pistoia Alliance.
    Wise J; Furness M; McWilliams S; Patton S
    Drug Discov Today; 2019 Nov; 24(11):2120-2125. PubMed ID: 31306783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Batch release of immunoglobulin and monoclonal antibody products].
    Gross S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1185-7. PubMed ID: 25200488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Marketing approval and market surveillance of medical devices in Germany: Where does policy integration take place?].
    Lang A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):320-4. PubMed ID: 25066351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Viral safety of biological medicinal products].
    Stühler A; Blümel J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1198-202. PubMed ID: 25123140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behringwerke anti-HIV test kits.
    Becker W
    Lancet; 1989 Aug; 2(8660):458-9. PubMed ID: 2569647
    [No Abstract]   [Full Text] [Related]  

  • 55. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
    Wesolowski LG; MacKellar DA; Facente SN; Dowling T; Ethridge SF; Zhu JH; Sullivan PS;
    AIDS; 2006 Aug; 20(12):1661-6. PubMed ID: 16868448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. US manufacturing guideline for IVD products.
    Donawa M
    Med Device Technol; 2000 Oct; 11(8):23-4. PubMed ID: 11185183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The systematic monitoring of transfusion microbiology test kit performance.
    Nightingale MJ; Ramskill S; Newham J; Kitchen A; Bukasa A; Wenham D; Reeves I
    Transfus Med; 2007 Oct; 17(5):404-12. PubMed ID: 17903142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective.
    Klimek L; Hoffmann HJ; Renz H; Demoly P; Werfel T; Matricardi PM; Muraro A; Schmid-Grendelmeier P; Cardona V; Papadopoulos NG
    Allergy; 2015 Oct; 70(10):1329-31. PubMed ID: 26105127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.